Login / Signup

Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.

Tetsuya MoriTomoo OsumiAkiko KadaKentaro OhkiYuhki KogaReiji FukanoNaoto FujitaTetsuo MitsuiTakeshi MoriAkiko M SaitoAtsuko NakazawaRyoji KobayashiMasahiro Sekimizu
Published in: European journal of haematology (2023)
The efficacy and safety of rituximab in combination with LMB chemotherapy in children with high-risk mature B-NHL was observed in Japan.
Keyphrases
  • diffuse large b cell lymphoma
  • locally advanced
  • hodgkin lymphoma
  • chronic lymphocytic leukemia
  • clinical trial
  • study protocol
  • squamous cell carcinoma
  • phase ii
  • chemotherapy induced
  • radiation therapy